ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 1 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $514 | +32.1% | 2,337 | +88.9% | 0.00% | – |
| Q1 2023 | $389 | -89.7% | 1,237 | -61.4% | 0.00% | – |
| Q4 2022 | $3,778 | -77.8% | 3,202 | -82.7% | 0.00% | – |
| Q3 2022 | $17,000 | -29.2% | 18,499 | -14.1% | 0.00% | – |
| Q2 2022 | $24,000 | -50.0% | 21,536 | -20.4% | 0.00% | – |
| Q1 2022 | $48,000 | – | 27,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 272,886 | $2,019,000 | 2.36% |
| AIGH Capital Management LLC | 459,261 | $3,331,000 | 0.60% |
| Worth Venture Partners, LLC | 105,413 | $780,000 | 0.29% |
| PERRITT CAPITAL MANAGEMENT INC | 16,000 | $118,000 | 0.06% |
| Minot Wealth Management LLC | 25,000 | $152,000 | 0.03% |
| Newbridge Financial Services Group, Inc. | 400 | $3,000 | 0.00% |
| UBS Group AG | 3,229 | $24,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,271 | $9,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 750 | $6,000 | 0.00% |